ClinicalTrials.govpublic full text
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
tuberculosis, tuberculosis, pulmonary, bacterial infections respiratory, lung diseases, mycobacterium infections, anti-bacterial agents, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896981
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.